You are here

Article info

Article menu
Basic tumor immunology
Original research
Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer

Authors

  • Wenbin Zhou Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Muxin Yu Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Hong Pan Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Wen Qiu Department of Immunology, Nanjing Medical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Hui Wang Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Mengjia Qian Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Nan Che Department of Rheumatology and Immunology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Kai Zhang Pancreatic Center and Department of General Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Xinrui Mao Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Li Li Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Ruoxi Wang Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Hui Xie Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Lijun Ling Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Yi Zhao Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Xiaoan Liu Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Cong Wang Department of Pathology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Qiang Ding Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Shui Wang Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles

Citation

Zhou W, Yu M, Pan H, et al
Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer
Journal for ImmunoTherapy of Cancer 2021;9:e002343. doi: 10.1136/jitc-2021-002343
Online issue publication 
May 06, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.